UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5435-5441

2007

Link zum Volltext

Verfügbarkeit prüfen

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

BMJ open, 2013-01, Vol.3 (4), p.e002560

2013

Link zum Volltext

Verfügbarkeit prüfen

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12511

2022

Link zum Volltext

Verfügbarkeit prüfen

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4385-4391

2009

Link zum Volltext

Verfügbarkeit prüfen

Gerichtsverhandlungen mittels Bild- und Tonübertragung mit im Ausland ansässigen Parteien und Beweispersonen

Zeitschrift für geistiges Eigentum, 2021, Vol.13 (4), p.357

2021

Link zum Volltext

Verfügbarkeit prüfen

Axenic Long-Term Cultivation of Pneumocystis jirovecii

Journal of fungi (Basel), 2023-09, Vol.9 (9), p.903

2023

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune disorders and paraneoplastic syndromes in thymoma

Journal of thoracic disease, 2020-12, Vol.12 (12), p.7571-7590

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556]

European journal of cancer (1990), 2024-05, p.114130-114130

2024

Link zum Volltext

Verfügbarkeit prüfen

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

European journal of cancer (1990), 2020-11, Vol.140, p.76-85

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

European journal of cancer (1990), 2022-07, Vol.170, p.106-118

2022

Link zum Volltext

Verfügbarkeit prüfen

81 - Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S35-S35

2023

Link zum Volltext

Verfügbarkeit prüfen

Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S35

2023

Link zum Volltext

Verfügbarkeit prüfen

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

European journal of cancer (1990), 2024-03, Vol.199, p.113556-113556, Article 113556

2024

Link zum Volltext

Verfügbarkeit prüfen

ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer care

Lung cancer (Amsterdam, Netherlands), 2021-01, Vol.151, p.44-52

2021

Link zum Volltext

Verfügbarkeit prüfen

Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis

Lung cancer (Amsterdam, Netherlands), 2023-05, Vol.179, p.107184-107184, Article 107184

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer: Update from the ARROW trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9089-9089

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids

Clinical lung cancer, 2021-09, Vol.22 (5), p.411-422

2021

Link zum Volltext

Verfügbarkeit prüfen

Pralsetinib in patients with RET fusion–positive non-small cell lung cancer: A plain language summary of the ARROW study

Future oncology (London, England), 2024-02, Vol.20 (6), p.297

2024

Link zum Volltext

Verfügbarkeit prüfen

Detection of clinically relevant gene fusions in plasma samples of lung cancer patients in routine molecular diagnostics

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24191-e24191

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing

Oncotarget, 2019-10, Vol.10 (55), p.5690-5702

2019

Link zum Volltext

Verfügbarkeit prüfen

Axenic Long-Term Cultivation of IPneumocystis jirovecii/I

Journal of fungi (Basel), 2023-09, Vol.9 (9)

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters

European journal of nuclear medicine and molecular imaging, 2010-10, Vol.37 (10), p.1842-1853

2010

Link zum Volltext

Verfügbarkeit prüfen

Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer

Diagnostic pathology, 2015-04, Vol.10 (1), p.21-21, Article 21

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour

European Journal of Nuclear Medicine, 2008-09, Vol.35 (9), p.1642-1650

2008

Link zum Volltext

Verfügbarkeit prüfen

Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease

Journal of pediatric hematology/oncology, 2006-08, Vol.28 (8), p.501-512

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial

Gerichtsverhandlungen mittels Bild- und Tonübertragung mit im Ausland ansässigen Parteien und Beweispersonen

Axenic Long-Term Cultivation of Pneumocystis jirovecii

Autoimmune disorders and paraneoplastic syndromes in thymoma

Corrigendum to "First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations" [Eur J Cancer 199 (2024) 113556]

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

81 - Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer care

Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis

Safety and efficacy of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer: Update from the ARROW trial

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids

Pralsetinib in patients with RET fusion–positive non-small cell lung cancer: A plain language summary of the ARROW study

Detection of clinically relevant gene fusions in plasma samples of lung cancer patients in routine molecular diagnostics

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing

Axenic Long-Term Cultivation of IPneumocystis jirovecii/I

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters

Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer

Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour

Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease

Suchergebnisse filtern